276 related articles for article (PubMed ID: 31084754)
1. Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: Cross-validation of a machine learning method.
Min X; Li M; Dong D; Feng Z; Zhang P; Ke Z; You H; Han F; Ma H; Tian J; Wang L
Eur J Radiol; 2019 Jun; 115():16-21. PubMed ID: 31084754
[TBL] [Abstract][Full Text] [Related]
2. [The value of machine learning models based on biparametric MRI for diagnosis of prostate cancer and clinically significant prostate cancer].
Qiao XM; Hu CH; Hu S; Hu CH; Wang XM; Shen JK; Ji LB; Song Y; Bao J
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1446-1454. PubMed ID: 37198106
[No Abstract] [Full Text] [Related]
3. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel, Multi-Parametric, MRI-Based Radiomic Nomogram for Differentiating Between Clinically Significant and Insignificant Prostate Cancer.
Zhang Y; Chen W; Yue X; Shen J; Gao C; Pang P; Cui F; Xu M
Front Oncol; 2020; 10():888. PubMed ID: 32695660
[No Abstract] [Full Text] [Related]
5. Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.
Wang J; Wu CJ; Bao ML; Zhang J; Wang XN; Zhang YD
Eur Radiol; 2017 Oct; 27(10):4082-4090. PubMed ID: 28374077
[TBL] [Abstract][Full Text] [Related]
6. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.
Tang Y; Yang CM; Su S; Wang WJ; Fan LP; Shu J
BMC Cancer; 2021 Nov; 21(1):1268. PubMed ID: 34819043
[TBL] [Abstract][Full Text] [Related]
7. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
Front Oncol; 2021; 11():825429. PubMed ID: 35155214
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
Zhang L; Jiang D; Chen C; Yang X; Lei H; Kang Z; Huang H; Pang J
Br J Radiol; 2022 Mar; 95(1131):20210191. PubMed ID: 34289319
[TBL] [Abstract][Full Text] [Related]
10. Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI.
Liu B; Cheng J; Guo DJ; He XJ; Luo YD; Zeng Y; Li CM
Clin Radiol; 2019 Nov; 74(11):896.e1-896.e8. PubMed ID: 31495546
[TBL] [Abstract][Full Text] [Related]
11. Discriminating malignant from benign testicular masses using machine-learning based radiomics signature of appearance diffusion coefficient maps: Comparing with conventional mean and minimum ADC values.
Fan C; Sun K; Min X; Cai W; Lv W; Ma X; Li Y; Chen C; Zhao P; Qiao J; Lu J; Guo Y; Xia L
Eur J Radiol; 2022 Mar; 148():110158. PubMed ID: 35066342
[TBL] [Abstract][Full Text] [Related]
12. T2-Weighted Image-Based Radiomics Signature for Discriminating Between Seminomas and Nonseminoma.
Zhang P; Feng Z; Cai W; You H; Fan C; Lv W; Min X; Wang L
Front Oncol; 2019; 9():1330. PubMed ID: 31850216
[No Abstract] [Full Text] [Related]
13. MRI-based radiomics signature for tumor grading of rectal carcinoma using random forest model.
He B; Ji T; Zhang H; Zhu Y; Shu R; Zhao W; Wang K
J Cell Physiol; 2019 Nov; 234(11):20501-20509. PubMed ID: 31074022
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
15. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Prediction of Extracapsular Extension: Radiomics Signature Based on Magnetic Resonance Imaging to Stage Prostate Cancer.
Ma S; Xie H; Wang H; Yang J; Han C; Wang X; Zhang X
Mol Imaging Biol; 2020 Jun; 22(3):711-721. PubMed ID: 31321651
[TBL] [Abstract][Full Text] [Related]
17. Clinically significant prostate cancer detection on MRI: A radiomic shape features study.
Cuocolo R; Stanzione A; Ponsiglione A; Romeo V; Verde F; Creta M; La Rocca R; Longo N; Pace L; Imbriaco M
Eur J Radiol; 2019 Jul; 116():144-149. PubMed ID: 31153556
[TBL] [Abstract][Full Text] [Related]
18. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
19. Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions.
Xu M; Fang M; Zou J; Yang S; Yu D; Zhong L; Hu C; Zang Y; Dong D; Tian J; Fang X
Eur J Radiol; 2019 May; 114():38-44. PubMed ID: 31005174
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study.
Jin P; Shen J; Yang L; Zhang J; Shen A; Bao J; Wang X
BMC Med Imaging; 2023 Mar; 23(1):47. PubMed ID: 36991347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
